CB
VRTX icon

Chemical Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Chemical Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.25M Sell
12,263
-76
-0.6% -$13.3K 0.26% 96
2019
Q1 		$2.27M Buy
12,339
+978
+9% +$181K 0.26% 93
2018
Q4 		$1.88M Buy
11,361
+7,394
+186% +$1.28M 0.23% 98
2018
Q3 		$765K Buy
3,967
+1,581
+66% +$282K 0.08% 205
2018
Q2 		$405K Buy
+2,386
New +$370K 0.04% 274

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Chemical Bank's VRTX Position: Q2 2019 in Review

Chemical Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 0.62% in Q2 2019, selling an estimated $13.3K and leaving 12,263 shares worth $2.25M. The position accounts for 0.26% of the portfolio, ranked #96.

Chemical Bank first reported a position in VRTX in Q2 2018 and has held it in 5 quarters since. The position peaked at $2.27M in Q1 2019. 716 funds tracked by Wall St. Rank hold VRTX as of Q2 2019.

  • Chemical Bank held 12,263 shares of Vertex Pharmaceuticals worth $2.25M as of Q2 2019.
  • Chemical Bank sold 76 Vertex Pharmaceuticals shares in Q2 2019, an estimated $13.3K.
  • Vertex Pharmaceuticals made up 0.26% of Chemical Bank's portfolio in Q2 2019, its #96 holding.
  • Chemical Bank first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
  • Chemical Bank's Vertex Pharmaceuticals position peaked at $2.27M in Q1 2019.
  • 716 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.